SCHEMBL19344407

SCHEMBL19344407

CC(C)(C)OC(=O)N1CCC2(CCCN2CC2CCC(n3ccc4c(Cl)ncnc43)O2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 3/20 0.43
▸ WDR77 Q9BQA1 2/20 0.43
▸ GPR119 Q8TDV5 2/20 0.37
▸ CNR2 P34972 2/20 0.36
▸ NAMPT P43490 7/20 0.36
▸ CNR1 P21554 1/20 0.35
▸ FAAH O00519 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584770 0.99 PRMT5 (0.43) PRMT5WDR77GPR119CNR2NAMPT
SCHEMBL23584761 0.98 PRMT5 (0.41) PRMT5WDR77GPR119CNR2NAMPT
SCHEMBL23584660 0.96 GPR119 (0.39) PRMT5WDR77GPR119CNR2NAMPT
SCHEMBL23584763 0.94 PRMT5 (0.40) PRMT5WDR77GPR119CNR2NAMPT
SCHEMBL19343827 0.91 PRMT5 (0.53) PRMT5WDR77GPR119CNR2
SCHEMBL19343917 0.91 PRMT5 (0.53) PRMT5WDR77GPR119CNR2
SCHEMBL19344038 0.90 GPR119 (0.36) PRMT5WDR77GPR119NAMPTOPRD1
SCHEMBL23584690 0.90 PRMT5 (0.52) PRMT5WDR77GPR119CNR2
SCHEMBL23584726 0.89 PRMT5 (0.50) PRMT5WDR77GPR119
SCHEMBL23584704 0.88 GPR119 (0.34) PRMT5WDR77GPR119NAMPTOPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
WO-2017153186-A1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-14 — — WO disclosed
Send feedback